ROLE OF CHRONIC ALCOHOL AND TOBACCO CONSUMPTION AS RISK FACTOR FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

被引:14
|
作者
MAIER, H
DIETZ, A
GEWELKE, U
SEITZ, HK
HELLER, WD
机构
关键词
D O I
10.1055/s-2007-998241
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
A case-control study of squamous cell carcinoma of the upper aerodigestive tract conducted in the ENT Departments of the University hospitals of Heidelberg and Giessen (FRG) provided information on the role of chronic tobacco and alcohol consumption as risk factors in 200 patients and 800 control subjects (4:1 matched design). - Only 4.5% of the tumour patients were non-smokers in contrast to 29.5% in the control group. The average tobacco and alcohol consumption in the patients was more than twice that high than in the control subjects. The highest alcohol and tobacco consumption was observed in patients suffering from oropharyngeal cancer. - It could be demonstrated that tobacco as well as alcohol increased the risk for head and neck cancer, dose-dependently, as separate risk factors. In heavy smokers (>60 pack years) a relative risk of 23.4 (alcohol-adjusted) was calculated. For heavy drinkers (> 100 g ethanol/day) a relative risk of 21.4 (tobacco-adjusted) was documented. Combined alcohol and tobacco consumption showed a synergistic effect and increased the cancer risk more in an multiplicative than in an additive manner: A daily ethanol consumption of more than 75 g/day combined with more than 50 pack years caused a risk value of 146.2.
引用
收藏
页码:505 / 511
页数:7
相关论文
共 50 条
  • [21] THE INCIDENCE OF HYPERCALCEMIA IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    DORMAN, EB
    YANG, H
    VAUGHAN, CW
    HONG, WK
    STRONG, MS
    HEAD & NECK SURGERY, 1984, 7 (02): : 95 - 98
  • [22] BLEOMYCIN IN ADVANCED SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK
    GREY, P
    MICHAELS, L
    MEDICAL JOURNAL OF AUSTRALIA, 1972, 2 (05) : 246 - &
  • [23] MULTIPLE PRIMARY SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    HONG, WK
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (02): : 182 - 183
  • [24] TIME TO RECURRENCE OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    STELL, PM
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1991, 13 (04): : 277 - 281
  • [25] Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
    Ferris, R. L.
    Blumenschein, G., Jr.
    Fayette, J.
    Guigay, J.
    Colevas, A. D.
    Licitra, L.
    Harrington, K.
    Kasper, S.
    Vokes, E. E.
    Even, C.
    Worden, F.
    Saba, N. F.
    Iglesias Docampo, L. C.
    Haddad, R.
    Rordorf, T.
    Kiyota, N.
    Tahara, M.
    Monga, M.
    Lynch, M.
    Geese, W. J.
    Kopit, J.
    Shaw, J. W.
    Gillison, M. L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1856 - 1867
  • [26] MICROSATELLITE INSTABILITY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    FIELD, JK
    KIARIS, H
    HOWARD, P
    VAUGHAN, ED
    SPANDIDOS, DA
    JONES, AS
    JOURNAL OF DENTAL RESEARCH, 1995, 74 (03) : 859 - 859
  • [27] AN INVIVO MODEL FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    BAKER, SR
    LARYNGOSCOPE, 1985, 95 (01): : 43 - 56
  • [28] CHEMOTHERAPY STRATEGIES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    ALSARRAF, M
    CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1984, 1 (04): : 323 - 355
  • [29] MICROSATELLITE INSTABILITY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    FIELD, JK
    KIARIS, H
    HOWARD, P
    VAUGHAN, ED
    SPANDIDOS, DA
    JONES, AS
    BRITISH JOURNAL OF CANCER, 1995, 71 (05) : 1065 - 1069
  • [30] IMMUNOMODULATION THERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    CORTESINA, G
    DESTEFANI, A
    SACCHI, M
    ROSSO, S
    GALEAZZI, E
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1993, 15 (03): : 266 - 270